In colon cancer cells treated as reported [26] with SFN or 6-SFN (Fig. 5A), primers designed to detect alternative splicing of BAZ1A around exon 13 (Fig. 5B) identified an increase in a 288-bp PCR product relative to the 384-bp product (Fig. 5C), indicative of exon exclusion. This evidence concerns the gene BAZ1A and malignant colon neoplasm.